Mannkind (MNKD) EBITDA Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,366.00 |
| Dec 31, 2025 | 12,189.00 |
| Sep 30, 2025 | 8,248.00 |
| Jun 30, 2025 | 396,442.00 |
| Mar 31, 2025 | 7,231.00 |
| Dec 31, 2024 | 10,549.00 |
| Sep 30, 2024 | 127,235.00 |
| Jun 30, 2024 | 549,895.00 |
| Mar 31, 2024 | 10,269.00 |
| Dec 31, 2023 | 6,166.00 |
| Sep 30, 2023 | 49,200.00 |
| Jun 30, 2023 | 53,108.00 |
| Mar 31, 2023 | 75,837.00 |
| Dec 31, 2022 | 60,111.00 |
| Sep 30, 2022 | 135,002.00 |
| Jun 30, 2022 | -535,841.00 |
| Mar 31, 2022 | 47,419.00 |
| Dec 31, 2021 | -9,612.00 |
| Sep 30, 2021 | -10,249.00 |
| Sep 30, 2017 | 10.00 Mn |